Business Context and Reporting Period
This Form 8-K reports on the 2023 Annual Meeting of Shareholders held by AmerisourceBergen Corporation (now Cencora, Inc.) on March 9, 2023. The filing details the results of five shareholder proposals and a change in board leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
- Election of Directors: All 11 nominees were elected. Notable "Against" votes included Steven H. Collis (8.9 million), Henry W. McGee (9.9 million), and Kathleen W. Hyle (6.5 million).
- Independent Auditor: Shareholders ratified the appointment of Ernst & Young LLP for fiscal year 2023.
- Executive Compensation (Say-on-Pay): Shareholders approved the advisory vote on executive compensation.
- Frequency of Say-on-Pay: Shareholders voted to hold advisory votes on executive compensation annually (1 Year).
- Shareholder Proposal: A proposal regarding shareholder ratification of termination pay was rejected by a significant margin (160 million votes against vs. 15 million for).
Management Commentary and Corporate Actions
Following the meeting, D. Mark Durcan assumed the role of Lead Independent Director, succeeding Jane E. Henney, M.D. The Board confirmed that future advisory votes on executive compensation will occur annually, consistent with shareholder preference, until the next frequency vote is required no later than the 2029 Annual Meeting.
Investor Verification Checklist
- Verify the specific reasons for the elevated "Against" votes for directors Steven H. Collis and Henry W. McGee.
- Review the Definitive Proxy Statement filed on January 27, 2023, for detailed context on the rejected shareholder proposal regarding termination pay.
- Confirm the transition of duties between Jane E. Henney, M.D., and D. Mark Durcan as Lead Independent Director.